Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program. With their patented Full Spectrum Profiling™ (FSP™) technology, Cytek ...

The Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards. The award highlights Cytek’s commitment to making cell analysis more ...

FREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) is showcasing its patented Full Spectrum Profiling™ ...

“I am pleased with our continued market penetration with our FSP™ technology, the increased number of instrument deployments and a substantial increase in adjusted EBITDA and positive cash flow ...

FREMONT, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot ...

FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This is the ...

“Our third quarter results are encouraging and demonstrate the strength of our established brand and technology and our market leadership position,” said Wenbin Jiang, CEO of Cytek Biosciences. “As we ...

Cytek is supporting ISAC in a shared mission to extend flow cytometry reach worldwide. In this effort, Cytek has launched a two-part research initiative. In the first phase of the program, Cytek is ...

There are still growth drivers that may positively play out in future quarters, so I'm still optimistic about Cytek Biosciences. Cytek's FY2024 adjusted EBITDA surged 77% YoY, indicating robust ...

Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (Nasdaq: CTKB) has announced that it has entered into a strategic partnership with Bio-Rad Laboratories, ...

FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences” or "Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2025 ...

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the ...